ST Pharm

South Korea

https://www.stpharm.co.kr

Drug Substance

Advanced Modalities

Analytical & Bioanalytical Services

Chemistry, Manufacturing and Controls

Manufacturing & Lab Equipment

Contract Research Organization

Company Overview

About

ST Pharm is a South Korean global API CDMO company founded in 1983, specializing in small molecule APIs, oligonucleotide therapeutics (ASO, siRNA, aptamers), and mRNA-LNP manufacturing. The company operates cGMP manufacturing facilities in South Korea and has a CRO subsidiary (AnaPath) in Switzerland and Spain for preclinical pathology services.

Key Expertise

oligonucleotide API manufacturing, mRNA-LNP production, small molecule API synthesis, enzymatic biotransformation, SMB chromatography, cryogenic reactions

Therapeutic Areas

Infectious Disease

Cardiovascular

Oncology

Quick Facts

HQ:South Korea

Capabilities & Services

Core Capabilities

Small Molecule API
API Manufacturing
mRNA Production

Dosage Forms

Oral Solid Dose

Sterile Injectable

Production Scales

Lab Scale

Pilot Scale

Phase I Clinical Trials

Phase II

Phase III Clinical Trials

Clinical

Commercial Scale

Large Scale (Metric Ton+)

Annual Capacity

Medium Clinical (100 - 1,000 kg/year)

Commercial (1,000 - 10,000 kg/year)

Markets Served

Asia

Manufacturing Facilities

2 sites worldwide

ST Pharm - South Korea Facility

South Korea

View on Map

ST PHARM - South Korea Facility

South Korea

View on Map

Site Capabilities

Formulation Development

Process Development

Scale-up

Certifications

FDA Registration

U.S. Food and Drug Administration

KFDA (South Korea)

Korea Food and Drug Administration

Customer Reviews

No reviews available yet.

Company Documents

No documents available.

Send Inquiry

Please log in to send an inquiry to this CDMO.